FR3118877B1 - Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant - Google Patents

Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant Download PDF

Info

Publication number
FR3118877B1
FR3118877B1 FR2100459A FR2100459A FR3118877B1 FR 3118877 B1 FR3118877 B1 FR 3118877B1 FR 2100459 A FR2100459 A FR 2100459A FR 2100459 A FR2100459 A FR 2100459A FR 3118877 B1 FR3118877 B1 FR 3118877B1
Authority
FR
France
Prior art keywords
composition
thiopyridinone
compound
yellowing
stabilization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2100459A
Other languages
English (en)
Other versions
FR3118877A1 (fr
Inventor
Romain TACHON
Amélie Prevot-Gueguiniat
Makoto Saito
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Priority to FR2100459A priority Critical patent/FR3118877B1/fr
Priority to PCT/JP2021/046653 priority patent/WO2022138471A1/fr
Priority to EP21840702.1A priority patent/EP4267098A1/fr
Priority to KR1020237020690A priority patent/KR20230110320A/ko
Priority to US18/267,333 priority patent/US20240082132A1/en
Publication of FR3118877A1 publication Critical patent/FR3118877A1/fr
Application granted granted Critical
Publication of FR3118877B1 publication Critical patent/FR3118877B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36Carboxylic acids; Salts or anhydrides thereof
    • A61K8/361Carboxylic acids having more than seven carbon atoms in an unbroken chain; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/06Emulsions
    • A61K8/062Oil-in-water emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • A61K8/375Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4933Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having sulfur as an exocyclic substituent, e.g. pyridinethione
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

STABILISATION D ’UN COMPOSÉ DE THIOPYRIDINONE ET RÉDUCTION DU JAUNISSEMENT DE LA COMPOSITION L E COMPRENANT La présente invention concerne une composition comprenant : (a) au moins un composé de thiopyridinone ; et (b) au moins un acide gras comprenant 18 atomes de carbone ou plus, dans laquelle la quantité du (des) (b) acide(s) gras comprenant 18 atomes de carbone ou plus dans la composition est de 10 % en poids ou plus, de préférence 12 % en poids ou plus, et de manière davantage préférée 14 % en poids ou plus, rapportée au poids total de la composition. La présente invention peut proposer une composition comprenant un (des) (a) composé(s) de thiopyridinone avec une stabilité accrue du (des) (a) composé(s) de thiopyridinone dans le temps, en particulier même lorsque la composition est maintenue pendant une durée relativement longue à température élevée, et avec un jaunissement réduit juste après l’ajout du composé de thiopyridinone à la composition. Figure pour l’abrégé : NEANT
FR2100459A 2020-12-22 2021-01-18 Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant Active FR3118877B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR2100459A FR3118877B1 (fr) 2021-01-18 2021-01-18 Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant
PCT/JP2021/046653 WO2022138471A1 (fr) 2020-12-22 2021-12-10 Stabilisation d'un composé thiopyridinone et réduction du jaunissement d'une composition le comprenant
EP21840702.1A EP4267098A1 (fr) 2020-12-22 2021-12-10 Stabilisation d'un composé thiopyridinone et réduction du jaunissement d'une composition le comprenant
KR1020237020690A KR20230110320A (ko) 2020-12-22 2021-12-10 티오피리디논 화합물을 포함하는 조성물 중의 티오피리디논 화합물의 안정화 및 조성물의 황변 저감
US18/267,333 US20240082132A1 (en) 2020-12-22 2021-12-10 Stabilization of thiopyridinone compound and yellowing reduction of composition comprising same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2100459 2021-01-18
FR2100459A FR3118877B1 (fr) 2021-01-18 2021-01-18 Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant

Publications (2)

Publication Number Publication Date
FR3118877A1 FR3118877A1 (fr) 2022-07-22
FR3118877B1 true FR3118877B1 (fr) 2023-11-17

Family

ID=75339886

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2100459A Active FR3118877B1 (fr) 2020-12-22 2021-01-18 Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant

Country Status (1)

Country Link
FR (1) FR3118877B1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023245461A1 (fr) * 2022-06-21 2023-12-28 L'oreal Composition pour l'administration d'un composé actif
FR3138869B1 (fr) * 2022-08-22 2024-08-23 Oreal Stabilisation de composé thiopyridinone et composition comprenant ce dernier

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2528378A (en) 1947-09-20 1950-10-31 John J Mccabe Jr Metal salts of substituted quaternary hydroxy cycloimidinic acid metal alcoholates and process for preparation of same
US2781354A (en) 1956-03-26 1957-02-12 John J Mccabe Jr Imidazoline derivatives and process
GB1567947A (en) 1976-07-02 1980-05-21 Unilever Ltd Esters of quaternised amino-alcohols for treating fabrics
DE3623215A1 (de) 1986-07-10 1988-01-21 Henkel Kgaa Neue quartaere ammoniumverbindungen und deren verwendung
JPH05124924A (ja) * 1991-04-09 1993-05-21 Sansho Seiyaku Co Ltd メラニン生成抑制外用剤
DE102005022292A1 (de) * 2005-05-13 2006-11-16 Basf Ag Verwendung von Peroxidzersetzern in kosmetischen und pharmazeutischen Mitteln zur Behandlung der Haut
FR2968661B1 (fr) * 2010-12-14 2016-01-01 Oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones
FR3045604B1 (fr) 2015-12-18 2018-01-26 L'oreal Procede de depigmentation des matieres keratiniques a l'aide de composes thiopyridinones

Also Published As

Publication number Publication date
FR3118877A1 (fr) 2022-07-22

Similar Documents

Publication Publication Date Title
FR3118877B1 (fr) Stabilisation d’un composé de thiopyridinone et réduction du jaunissement de la composition le comprenant
EP0752014B1 (fr) Compositions d'alliages d'argent
EP0396236B1 (fr) Alliage à base de titane, du type alpha-bêta et présentant une résistance mécanique élévée
FR2403363A1 (fr) Composition de fluoro-elastomeres
US5037708A (en) Silver palladium alloy
FR3118871B1 (fr) stabilisation d’un composé de thiopyridinone dans une composition du type E/H
RU2346070C2 (ru) Высокопрочный титановый сплав
EP3693471A1 (fr) Formulation stabilisée pour la détection de luminescence de luciférase et de nucléosides phosphates
JPS6327542A (ja) ゴム組成物
FR3136662B1 (fr) Composition antioxydante comprenant un composé thiopyridinone
JPS6220850A (ja) 耐変色性銀合金
Krozowski et al. Mutations in the 11β-hydroxysteroid dehydrogenase type II enzyme associated with hypertension and possibly stillbirth
US2273805A (en) Platinum alloy
DE60330309D1 (de) Herstellung von magnesium-zirconium-legierungen
FR3111545B1 (fr) Composition cosmetique pour application sur la peau contenant une haute quantite de polyol(s)
FR2855759A1 (fr) Composition aqueuse stabilisee, desinfectante a base d'un complexe d'acide peracetique de peroxyde d'hudrogene et d'acide stabilise, ainsi qu'un procede pour sa fabrication
NZ247010A (en) Dioxolan-5-ylmethoxy substituted biphenyl, benzophenone diphenyl ether and diphenylthioether derivatives; pesticidal compositions and 1,2-dihydroxypropane intermediates
JPH11207487A (ja) 高温はんだ付用Zn合金
US4482323A (en) Dental restorations using novel palladium silver alloy casting
McBride et al. Hemoglobin Expression and Function in Human Corneal Epithelium
JPH0639649B2 (ja) 靭性の優れた高耐食性Ni基合金
JP2788594B2 (ja) 歯科鋳造用合金
SU1346597A1 (ru) Стекло
MALY et al. The intra-acinar distribution patterns of alcohol-dehydrogenase activity in the liver of juvenile, castrated and testosterone-treated rats
BABA et al. Studies on the Nutrition of the Rice Plant with Reference to the Occurrence of the so-called" Akagare" Disease.: V. Changes in the respiratory rate and activities of some enzymes as affected by the occurrence of the disease

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20220722

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4